Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 266Neoplasms 231Carcinoma, Non-Small-Cell Lung 209Colorectal Neoplasms 155Prostatic Neoplasms 148Lung Neoplasms 121Neoplasm Metastasis 112Ovarian Neoplasms 105Multiple Myeloma 98Pancreatic Neoplasms 91Leukemia, Myeloid, Acute 82Squamous Cell Carcinoma of Head and Neck 76Endometrial Neoplasms 67Melanoma 66Stomach Neoplasms 63Glioblastoma 61Recurrence 58Brain Neoplasms 56Carcinoma, Hepatocellular 53Urinary Bladder Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Head and Neck Neoplasms 51Carcinoma, Renal Cell 51Triple Negative Breast Neoplasms 50Lymphoma 50Hematologic Neoplasms 47Glioma 46Esophageal Neoplasms 46Colonic Neoplasms 46Small Cell Lung Carcinoma 43

Interventions

obinutuzumab 1glofitamab 1Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Cytokine Release Syndrome × 30 days × Clear all
NCT06806033 2026-05-26

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Hoffmann-La Roche

Phase 2 Recruiting
100 enrolled
Lymphoid

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06377059 2026-05-15

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Rigshospitalet, Denmark

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡